155 related articles for article (PubMed ID: 37933642)
41. CD155/TIGIT signaling regulates the effector function of tumor-infiltrating CD8+ T cell by NF-κB pathway in colorectal cancer.
Li S; Ding J; Wang Y; Wang X; Lv L
J Gastroenterol Hepatol; 2022 Jan; 37(1):154-163. PubMed ID: 34734434
[TBL] [Abstract][Full Text] [Related]
42. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
Novoa Díaz MB; Carriere P; Gigola G; Zwenger AO; Calvo N; Gentili C
World J Gastroenterol; 2022 Jul; 28(26):3177-3200. PubMed ID: 36051345
[TBL] [Abstract][Full Text] [Related]
43. PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.
Sawada M; Goto K; Morimoto-Okazawa A; Haruna M; Yamamoto K; Yamamoto Y; Nakagawa S; Hiramatsu K; Matsuzaki S; Kobayashi E; Kawashima A; Hirata M; Iwahori K; Kimura T; Ueda Y; Kimura T; Wada H
Int Immunol; 2020 May; 32(6):397-405. PubMed ID: 32009163
[TBL] [Abstract][Full Text] [Related]
44. Co-expression of LAG3 and TIM3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients.
Ma Q; Liu J; Wu G; Teng M; Wang S; Cui M; Li Y
Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1002-1009. PubMed ID: 29905955
[TBL] [Abstract][Full Text] [Related]
45. Targeting PD-1 and Tim-3 Pathways to Reverse CD8 T-Cell Exhaustion and Enhance Ex Vivo T-Cell Responses to Autologous Dendritic/Tumor Vaccines.
Liu J; Zhang S; Hu Y; Yang Z; Li J; Liu X; Deng L; Wang Y; Zhang X; Jiang T; Lu X
J Immunother; 2016 May; 39(4):171-80. PubMed ID: 27070448
[TBL] [Abstract][Full Text] [Related]
46. EpCAM Aptamer-Functionalized Cationic Liposome-Based Nanoparticles Loaded with miR-139-5p for Targeted Therapy in Colorectal Cancer.
Zhao Y; Xu J; Le VM; Gong Q; Li S; Gao F; Ni L; Liu J; Liang X
Mol Pharm; 2019 Nov; 16(11):4696-4710. PubMed ID: 31589818
[TBL] [Abstract][Full Text] [Related]
47. Quantitative multiplex immunofluorescence analysis identifies infiltrating PD1
Liang H; Li H; Xie Z; Jin T; Chen Y; Lv Z; Tan X; Li J; Han G; He W; Qiu N; Jiang M; Zhou J; Xia H; Zhan Y; Cui L; Guo W; Huang J; Zhang X; Wu YL
Thorac Cancer; 2020 Oct; 11(10):2941-2954. PubMed ID: 32894006
[TBL] [Abstract][Full Text] [Related]
48. Yangyin Fuzheng Jiedu Prescription exerts anti-tumor immunity in hepatocellular carcinoma by alleviating exhausted T cells.
Yan F; Wang X; Xie Y; Liu X; Yu L; Wang P; Li T; Wang S; Li W; Yang Z
Phytomedicine; 2021 Oct; 91():153722. PubMed ID: 34488188
[TBL] [Abstract][Full Text] [Related]
49. CD8
E J; Yan F; Kang Z; Zhu L; Xing J; Yu E
Hum Immunol; 2018 Jun; 79(6):446-452. PubMed ID: 29544815
[TBL] [Abstract][Full Text] [Related]
50. CD8
Tao J; Han D; Gao S; Zhang W; Yu H; Liu P; Fu R; Li L; Shao Z
J Cell Mol Med; 2020 Jan; 24(1):1046-1058. PubMed ID: 31756785
[TBL] [Abstract][Full Text] [Related]
51. Salvia mitiorrhiza Bunge aqueous extract attenuates infiltration of tumor-associated macrophages and potentiates anti-PD-L1 immunotherapy in colorectal cancer through modulating Cox2/PGE2 cascade.
Song M; Qian C; Zhang T; Tang Y; Zhou Y; Wei Z; Wang A; Zhong C; Zhao Y; Lu Y
J Ethnopharmacol; 2023 Nov; 316():116735. PubMed ID: 37286115
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
53. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
[TBL] [Abstract][Full Text] [Related]
54. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
[TBL] [Abstract][Full Text] [Related]
55. Interaction of Breast Cancer and Insulin Resistance on PD1 and TIM3 Expression in Peripheral Blood CD8 T Cells.
Martín-Manzo MV; Lara C; Vargas-de-Leon C; Carrero J; Queipo G; Fonseca-Sanchez M; Mejia-Dominguez NR; Kershenobich D; Mummidi S; Zentella-Dehesa A; Hernandez J
Pathol Oncol Res; 2019 Jul; 25(3):1233-1243. PubMed ID: 30759303
[TBL] [Abstract][Full Text] [Related]
56. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis.
Fang H; Huang Y; Luo Y; Tang J; Yu M; Zhang Y; Zhong M
Cell Immunol; 2022 Jan; 371():104458. PubMed ID: 34847407
[TBL] [Abstract][Full Text] [Related]
57. FOLFOX Chemotherapy Ameliorates CD8 T Lymphocyte Exhaustion and Enhances Checkpoint Blockade Efficacy in Colorectal Cancer.
Guan Y; Kraus SG; Quaney MJ; Daniels MA; Mitchem JB; Teixeiro E
Front Oncol; 2020; 10():586. PubMed ID: 32391270
[No Abstract] [Full Text] [Related]
58. Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.
Oka D; Nishimura K; Shiba M; Nakai Y; Arai Y; Nakayama M; Takayama H; Inoue H; Okuyama A; Nonomura N
Int J Cancer; 2007 Jun; 120(12):2576-81. PubMed ID: 17290398
[TBL] [Abstract][Full Text] [Related]
59. ITGAE Defines CD8+ Tumor-Infiltrating Lymphocytes Predicting a better Prognostic Survival in Colorectal Cancer.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
EBioMedicine; 2018 Sep; 35():178-188. PubMed ID: 30100393
[TBL] [Abstract][Full Text] [Related]
60. Cryptotanshinone Induces Necroptosis Through Ca
Zhao W; Song Y; Wang QQ; Han S; Li XX; Cui Y; Gao H; Yuan R; Yang S
Curr Mol Pharmacol; 2022; 15(7):1009-1023. PubMed ID: 35086466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]